Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03294317 · ClinicalTrials.gov registry record
Imaging Study of Lead Implant for His Bundle Pacing
A clinical trial of Cardiac Pacemaker, Artificial, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
- Completed
- Registry status
- 70
- Enrollment target
- 3
- Study locations
NCT03294317 is a study of Cardiac Pacemaker, Artificial that has completed, run by Medtronic Cardiac Rhythm and Heart Failure. The registered enrollment target is 70 participants. The trial reports 3 study locations across 3 states.
The verdict
NCT03294317, a study of Cardiac Pacemaker, Artificial, has completed, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
- COMPLETED
- Registry status
- 70 participants
- Enrollment target
- 3
- Study locations
Study Summary
The purpose of this research study is to assess the implant success proportion of the Medtronic SelectSecure MRI SureScan Model 3830 pacing lead at the bundle of His for His bundle pacing.
Conditions Studied
Interventions
- DEVICE His bundle pacing
Study Locations (3)
Indiana
- Indiana University - Krannert Institute of Cardiology - Indianapolis
Pennsylvania
- Geisinger Wyoming Valley Medical Center - Wilkes-Barre
Virginia
- Virginia Commonwealth University Health System - Richmond
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2017-11-29 |
| Est. Completion | 2020-01-24 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03294317
The ClinicalTrials.gov registry entry for NCT03294317 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic Cardiac Rhythm and Heart Failure, which has 115 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cardiac Pacemaker, Artificial appearing as the primary indexed condition, and to 1 intervention - of which His bundle pacing is the first listed.
NCT03294317 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Indiana, Pennsylvania, Virginia.
Frequently Asked Questions
What is clinical trial NCT03294317 about?
NCT03294317 is a clinical study titled "Imaging Study of Lead Implant for His Bundle Pacing". The purpose of this research study is to assess the implant success proportion of the Medtronic SelectSecure MRI SureScan Model 3830 pacing lead at the bundle of His for His bundle pacing.
What is the current status of trial NCT03294317?
This trial is currently completed. The enrollment target is 70 participants. The study started on 2017-11-29. Estimated completion is 2020-01-24.
What conditions does trial NCT03294317 study?
This clinical trial studies the following conditions: Cardiac Pacemaker, Artificial.
What interventions are being tested in trial NCT03294317?
The interventions under investigation include: His bundle pacing (DEVICE).
Who is sponsoring clinical trial NCT03294317?
This trial is sponsored by Medtronic Cardiac Rhythm and Heart Failure, which has 115 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03294317 being conducted?
This trial has 3 study locations across Indiana, Pennsylvania, Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cardiac Pacemaker, Artificial
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.